Patents by Inventor Maria Elena Pero

Maria Elena Pero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DELTA-2-TUBULIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR PERIPHERAL NEUROPATHY
    Publication number: 20240110931
    Abstract: The present disclosure relates to delta-2-tubulin and its use as a biomarker for determining if a subject is at risk of developing peripheral neuropathy or if a subject has developed peripheral neuropathy. The present disclosure further relates to methods for the treatment of peripheral neuropathy in a subject and assays for identifying compounds that can be used to treat and/or prevent peripheral neuropathy.
    Type: Application
    Filed: December 5, 2023
    Publication date: April 4, 2024
    Applicants: The Trustees of Columbia University in The City of New York, Università Degli Studi Di Milano-Bicocca
    Inventors: Francesca Bartolini, Maria Elena Pero, Guido Cavaletti
  • Delta-2-tubulin as a biomarker and therapeutic target for peripheral neuropathy
    Patent number: 11874284
    Abstract: The present disclosure relates to delta-2-tubulin and its use as a biomarker for determining if a subject is at risk of developing peripheral neuropathy or if a subject has developed peripheral neuropathy. The present disclosure further relates to methods for the treatment of peripheral neuropathy in a subject and assays for identifying compounds that can be used to treat and/or prevent peripheral neuropathy.
    Type: Grant
    Filed: May 27, 2020
    Date of Patent: January 16, 2024
    Assignees: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, UNIVERSITÀ DEGLI STUDI DI MILANO-BICOCCA
    Inventors: Francesca Bartolini, Maria Elena Pero, Guido Cavaletti
  • DELTA-2-TUBULIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR PERIPHERAL NEUROPATHY
    Publication number: 20200333359
    Abstract: The present disclosure relates to delta-2-tubulin and its use as a biomarker for determining if a subject is at risk of developing peripheral neuropathy or if a subject has developed peripheral neuropathy. The present disclosure further relates to methods for the treatment of peripheral neuropathy in a subject and assays for identifying compounds that can be used to treat and/or prevent peripheral neuropathy.
    Type: Application
    Filed: May 27, 2020
    Publication date: October 22, 2020
    Applicants: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, UNIVERSITÀ DEGLI STUDI DI MILANO-BICOCCA
    Inventors: Francesca Bartolini, Maria Elena Pero, Guido Cavaletti